A detailed history of Wellington Management Group LLP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 10,127,528 shares of GH stock, worth $314 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
10,127,528
Previous 3,508,743 188.64%
Holding current value
$314 Million
Previous $101 Million 129.17%
% of portfolio
0.04%
Previous 0.02%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$22.3 - $36.29 $148 Million - $240 Million
6,618,785 Added 188.64%
10,127,528 $232 Million
Q2 2024

Aug 13, 2024

BUY
$16.07 - $31.84 $56.4 Million - $112 Million
3,508,743 New
3,508,743 $101 Million
Q4 2023

Feb 12, 2024

BUY
$21.58 - $29.5 $18 Million - $24.6 Million
834,084 New
834,084 $22.6 Million
Q3 2023

Nov 14, 2023

SELL
$25.8 - $39.97 $23.2 Million - $35.9 Million
-897,872 Reduced 57.19%
672,098 $19.9 Million
Q2 2023

Aug 14, 2023

BUY
$20.94 - $38.01 $32.9 Million - $59.7 Million
1,569,970 New
1,569,970 $56.2 Million
Q1 2021

May 17, 2021

SELL
$127.04 - $179.1 $224,606 - $316,648
-1,768 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$99.96 - $135.93 $151,939 - $206,613
-1,520 Reduced 46.23%
1,768 $228,000
Q3 2020

Nov 16, 2020

SELL
$80.32 - $111.8 $728,984 - $1.01 Million
-9,076 Reduced 73.41%
3,288 $368,000
Q2 2020

Aug 14, 2020

BUY
$60.49 - $97.5 $368,202 - $593,482
6,087 Added 96.97%
12,364 $1 Million
Q1 2020

May 14, 2020

SELL
$59.04 - $88.81 $297,148 - $446,980
-5,033 Reduced 44.5%
6,277 $437,000
Q4 2019

Feb 11, 2020

BUY
$59.49 - $82.78 $672,831 - $936,241
11,310 New
11,310 $884,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.17B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.